

































	 Thiazole	 Schiff	 base	 (H2L)	 ligand	 was	 synthesized	 from	 condensation	 of	 2‐amino‐4‐phenylthiazole	with	4,6‐diacetylresorcinol	in	the	molar	ratio	2:1.	A	series	of	Ag(I),	Mn(II),	
Co(II)	 and	 Ni(II)	 complexes	 of	 H2L	 ligand	was	 prepared	 and	 investigated	 by	 elemental	
analysis,	IR,	UV,	1H	NMR,	TGA	and	mass	spectral	data.	Thiazol	Schiff	base	ligand	has	two	
bidentate	 sets	 of	 N‐O	 units	 which	 can	 coordinate	 with	 two	metal	 ions	 to	 afford	 novel	
binuclear	 metal	 complexes.	 The	 directions	 of	 the	 coordinate	 bonds	 are	 from	 nitrogen	
atoms	 of	 the	 azomethine	 groups	 and	 oxygen	 atoms	 of	 the	 phenolic	 groups.	 All	 of	 the	
newly	 synthesized	 complexes	 were	 evaluated	 for	 their	 antimicrobial	 activities.	 The	
results	 showed	 the	 Ag(I)	 complex	 exhibited	 better	 activities	 than	 the	 commercial	
antimicrobial	reference	drugs.	The	metal	complexes	were	also	evaluated	for	their	in‐vitro	
anti‐colon	human	cancer	 (HCT‐116)	and	mammalian	 cells	 of	 the	African	green	monkey	
kidney	 (VERO).	 The	 Ag(I)	 and	 Co(II)	 complexes	with	 selectivity	 index	 value	 17.00	 and	
15.63,	respectively,	exhibited	better	activity	than	methotrexate	as	a	reference	drug	with	
selectivity	 index	 value	 13.30,	 while	 complexes	 Ni(II)	 and	 Mn(II)	 with	 selectivity	 index	
values	 9.30	 and	 8.59,	 respectively,	 were	 found	 to	 be	 nearly	 as	 active	 as	methotrexate.	
Molecular	 docking	 studies	 further	 helped	 in	 understanding	 the	 mode	 of	 action	 of	 the	
compounds	 through	 their	various	 interactions	with	 the	active	 sites	of	 the	dihydrofolate	
reductase	enzyme.	The	observed	activity	of	 the	Ag(I),	Mn(II)	and	Ni(II)	complexes	gave	















thiazole	 moieties	 and/or	 transition	 metal	 ions,	 which	 can	
avoid	such	side	effects.	Schiff	base	ligands	play	a	central	role	as	
chelating	 ligands	 in	 transition	 metal	 coordination	 chemistry	
[1‐3].	A	bimetallic	 core	 is	 versatile	 at	 the	 active	 site	 of	many	
metalloenzymes	 and	 plays	 an	 essential	 role	 in	 biological	
systems	via	the	interplay	of	a	pair	of	metal	ions	[4].	In	the	last	
two	 decades,	 a	 large	 number	 of	 bimetallic	 Schiff	 base	
complexes	of	different	structural	types	have	been	synthesized	
and	 characterized	 [5,6].	 These	 complexes	 vary	 in	 their	 new	
applications,	of	biological	activities	[7‐11].		
2‐Amino‐4‐phenylthiazole	 and	 its	 Schiff	 base	 derivatives,	
which	 are	 formed	 by	 the	 condensation	 reaction	 with	
aldehydes	 and	 ketones	 showed	 significant	 antibacterial	 and	
antifungal	 and	 anticancer	 activities	 [12‐15].	 Additionally,	 the	
same	 behaviors	where	 also	 identified	 in	 the	 transition	metal	
complexes	of	2‐amino‐4‐phenylthiazole	derivatives	[16‐19].	
In	our	previous	published	work	[20],	we	managed	to	get	a	
number	 of	 transition	 metal	 complexes	 with	 ligand	 contains	
thiazole	 group	and	study	 their	anti‐microbial	 and	anti‐cancer	
tumors	effects.	In	extension	to	this	work	in	our	laboratory,	we	
have	 succeeded	 to	 synthesize	 Ag(I),	 Mn(II),	 Co(II)	 and	 Ni(II)	
thiazole	 Schiff	 base	 ligand.	 Anti‐microbial	 and	 anti‐cancer	
studies	were	investigated.		
In	 the	 present	 study,	 the	 thiazole	 Schiff	 base,	 H2L,	 ligand	
was	prepared	by	the	condensation	of	4,6‐diacetylresorcinol,	as	
a	starting	material,	with	2‐amino‐4‐phenylthiazole	as	cited	 in	
the	 literature	 [20].	 The	 reaction	 of	 this	 ligand	with	 silver(I),	
nickel(II),	cobalt(II),	and	manganese(II)	 ions,	 in	the	1:2	molar	
ratio	 (ligand	 :	 metal	 ion)	 were	 studied.	 The	 newly	 prepared	
metal	 complexes	 of	 this	 ligand	 were	 identified	 by	 different	
physicochemical	and	spectroscopic	techniques.	
The	Schiff	base,	H2L,	 ligand	and	its	metal	complexes	were	
investigated	 for	 antibacterial	 and	antifungal	properties.	Eight	
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pathogenic	microorganisms	were	 used	 for	 this	 investigation.	
The	 Gram‐positive	 bacteria	 used	were	 Staphylococcus	aureus	
(RCMB	 010027),	 Streptococcus	 pneumoniae	 (RCMB	 010010)	
and	 Bacillus	 subtilis	 (RCMB	 010067).	 The	 Gram‐negative	
bacteria	 were	 Pseudomonas	 aeruginosa	 (RCMB	 010043),	
Klebsiella	 pneumoniae	 (RCMB	 0010093)	 and	 Escherichia	 coli	
(RCMB	 010052).	 Two	 fungi,	 Aspergillus	 fumigatus	 (RCMB	
02568)	 and	 Candida	 albicans	 (RCMB	 05036),	 were	 also	
utilized.		
Currently,	 colorectal	 cancer	 is	 the	 third	 most	 commonly	
diagnosed	 cancer	 in	 males	 worldwide	 and	 the	 fourth	 most	
common	 in	 females.	 Thiazole	 Schiff	 base	 ligands	 and	 their	
metal	 complexes	 are	 one	 of	 the	 drugs	 involved	 in	 the	
cytotoxicity	 of	 anticancer.	 Therefore,	 this	 present	 work	 is	









to	 the	 methods	 specified	 in	 the	 literature	 [20].	 Silver(I),	
manganese(II),	 cobalt(II)	 and	 nickel(II)	 ions	 were	 used	 as	
nitrate	 salts	 and	 were	 Merck	 or	 BDH.	 Organic	 solvents	










heated	 to	 reflux	 for	4	h.	Yellow	crystals	were	 filtered	off	 and	
washed	with	a	few	amount	of	ethanol	then	ether	and	air	dried.	
Fine	crystals	were	obtained	by	recrystallization	from	ethanol.	
Color:	Yellow.	 Yield:	 7.98	 g	 (78.2%).	M.p.:	 212‐213	 °C.	 FT‐IR	
(KBr,	 ,	 cm‐1):	 3400‐3166	 (OH)	 (br,	 alcohol),	 3050	 (CH‐
aromatic),	2990	(CH‐aliphatic)1629	(C=N).	1H	NMR	(400	MHz,	











The	 mixtures	 of	 the	 H2L	 ligand	 (2.55	 g;	 5.0	 mmol)	 with	
metal	 salts	 (10	mmol)	 in	50	mL	ethanol	were	stirred	on	cold	
for	 30	 minutes	 and	 then	 heated	 to	 reflux,	 for	 3	 hrs.	 The	
resulting	 precipitates	were	 formed	 on	 cold	 after	 evaporation	
until	near	dryness.	The	products	were	filtered	off,	washed	with	
ethanol	 and	 ether,	 and	 then	 air	 dried.	 The	 complexes	 are	
soluble	in	most	common	solvents.	The	obtained	products	were	







(25	 mL)	 was	 added	 gradually	 with	 constant	 stirring	 to	
Ni(NO3)2.6H2O,	(2.907	g,	10	mmol)	in	ethanol	(25	mL).	The	pH	
of	the	mixture	was	2.4.	The	mixture	was	stirred	on	cold	for	30	
min	and	 then	heated	 to	 reflux	 for	3	hrs.	A	yellow	precipitate	
was	formed	on	cold	after	evaporation	of	the	solvent	on	a	water	
bath	near	dryness.	 Color:	Yellow.	Yield:	 5.35	 g	 (59.8%).	M.p.:	
177‐178	°C.	FT‐IR	(KBr,	,	cm‐1):	3380‐3315	(OH)	(br,	alcohol),	
3100	 (CH‐aromatic),	 2930	 (CH‐aliphatic),	 1742,	 1383,	 855	









Analysis	 of	 metal	 ions	 after	 the	 dissolution	 of	 the	 solid	
complex	 in	 hot	 concentrated	 nitric	 acid,	 HNO3,	 then	 diluting	
with	 distilled	 water	 and	 filtering	 to	 remove	 the	 precipitated	
ligand.	 The	 solution	 was	 neutralized	 with	 ammonia	 solution	
and	the	metal	ions	were	then	titrated	with	EDTA	using	either	
murexide	 or	 Eriochrome	 Black	 T	 indicators	 [21‐23].	 Carbon,	
hydrogen,	nitrogen	and	sulfur	contents	were	carried	out	at	the	
Microanalytical	Center,	Cairo	and	Al‐Azhar	University.	The	FT‐
IR	spectra	 (4000‐400	cm‐1)	of	 the	compounds	were	 recorded	
as	 KBr	 discs	 using	 FT‐IR	 (Shimadzu)	 spectrophotometer	
model	 8400.	 Electronic	 spectra	 of	 the	 ligand	 and	 its	 metal	





the	 Gouy	 method	 at	 room	 temperature	 using	 a	 magnetic	
susceptibility	 balance	 (Johnson	Matthey,	 Alfa	 product,	 Model	
No.	 MKI).	 Effective	 magnetic	 moments	 were	 calculated	 from	
the	expression	µeff	=	2.828	(χM.T)1/2	B.M.,	where	χM	is	the	molar	
susceptibility	 corrected	 using	 Pascal’s	 constants	 for	 the	
diamagnetism	 of	 all	 atoms	 in	 the	 compounds	 and	 T	 is	 the	
absolute	temperature	[24].	Molar	conductance	of	the	solutions	
in	mmoles	of	 the	 solid	 complexes	 in	DMF	were	measured	on	
pH	and	conductmeter	Instrument	model	14831	(Italy).	Melting	




were	 obtained	 using	 a	 Shimadzu	 TGA‐50H	 instrument.	 Ther‐
mal	analyzer	equipped	with	a	thermo‐balance.	The	sample	was	





The	 in	 vitro	 evaluation	 of	 antibacterial	 and	 antifungal	
activities	 was	 performed	 using	 standardized	 disc‐agar	
diffusion	 method	 [25].	 The	 activity	 of	 the	 synthesized	
compounds	 was	 determined	 against the	 following	 sensitive	
organisms:	 Staphylococcus	 aureus	 (RCMB	 010027),	
Streptococcus	pneumoniae	(RCMB	010010)	and	Bacillus	subtilis	
(RCMB	 010067)	 as	 Gram‐positive	 bacteria;	 Pseudomonas	
aeruginosa	 (RCMB	 010043),	 Klebsiella	 pneumoniae	 (RCMB	
0010093)	 and	 Escherichia	 coli	 (RCMB	 010052)	 as	 Gram‐




standard	 reference	 with	 the	 Gram‐negative	 bacteria	 and	
amphotericin	B	was	used	as	the	standard	antifungal	reference	
control.	The	tested	compounds	were	dissolved	in	DMF	(which	
has	 no	 inhibition	 activity)	 to	 obtain	 concentrations	 of	 5	









No	 Compound	 Molecular	formula	 Yield	(%)	 Colour	 M.p.	(°C)	 Elemental	analyses;	Calcd.	(Found)	%	
C H N	 S	 M










































Uniform	 size	 filter	 paper	 disks	 (3	 disks	 per	 compound)	
were	impregnated	with	equal	volume	(10	µL)	from	the	specific	
concentration	 of	 dissolved	 tested	 compounds	 and	 then	
carefully	 placed	 on	 the	 incubated	 agar	 surface.	 After	
incubation	for	36	hrs	at	27	°C	in	the	case	of	bacteria	and	for	48	
hours	at	24	°C	in	the	case	of	fungi,	inhibition	of	the	organisms	





The	 compounds	 were	 tested	 for	 any	 cytotoxic	 activity	
against	 the	 colon	 carcinoma	 (HCT‐116)	 cell	 line.	 When	 the	
cells	 reached	 confluence	 (usually	 after	 24	 hrs),	 the	 cell	
suspension	of	the	tumor	cell	lines	was	prepared	in	a	complete	
growth	 medium	 (DMEM)	 supplemented	 with	 50	 μg/mL	
gentamycin	 [28].	 The	 aliquots	 of	 100	 μL	 of	 cell	 suspension	
(1×105	 cell/mL)	 were	 added	 to	 each	 plate.	 The	 blank	 wells	
contained	 complete	medium	 in	 place	 of	 cell	 suspension.	 The	
cells	 were	 incubated	 for	 24	 hrs	 at	 37	 °C	 in	 a	 humidified	
incubator	 with	 5%	 CO2.	 After	 the	 formation	 of	 a	 complete	
monolayer	cell	 sheet	 in	each	well	of	 the	plate,	 serial	 two‐fold	
dilutions	 of	 the	 compounds	 were	 added	 into	 a	 96‐tissue	
culture	 plate	 using	 a	 multichannel	 pipette	 (Eppendorf,	
Germany).	 The	 treated	 and	 untreated	 cells	 were	 allowed	 to	
grow	in	the	presence	of	test	compounds	by	further	incubating	
the	plates	for	24	hours.	The	plates	were	covered	with	a	plate	
sealer	 and	 then	 incubated	 at	 37	 °C.	 To	 obtain	 quantitative	





is	 proportional	 to	 the	 number	 of	 surviving	 cells.	 Each	









Cell	 toxicity	 was	 monitored	 by	 determining	 the	 effect	 of	
silver	nanoparticles	on	cell	morphology	and	cell	viability	[31].	
The	cytotoxicity	assay	was	monitored	on	VERO	cells	using	0.1	
mL	 of	 cell	 suspension,	 involving	 10,000	 cells	 seeded	 in	 each	
well	 of	 a	 96‐well	 microtitre	 plate	 (Falcon,	 NJ,	 USA).	 Fresh	
maintenance	medium	containing	different	dilutions	of	the	test	
sample	was	added	after	24	hours	of	seeding.	Control	cells	were	




replaced	 by	 fresh	medium.	 The	 cells	 in	 each	well	 were	 then	
stained	 and	 analyzed	 as	 described	 in	 the	 antitumor	 section.	
The	 absorbance	 was	 detected	 at	 490	 nm	 using	 a	microplate	
ELISA	 reader	 (Sunrise	 TECAN	 Inc.	 USA).	 The	 absorbance	 of	
untreated	cells	was	considered	as	100%.		
The	 cell	 cytotoxic	 effect	 (CC50)	 of	 each	 tested	 compound	
was	calculated	using	the	following	formula:	percentage	of	cell	
cytotoxic	 effect	 =	 [1‐(ODt/ODc)]×100%,	 where	 ODt	 and	 ODc	





Thymidylate	 synthase	 and	 dihydrofolate	 reductase	 are	
among	 the	 main	 targets	 involved	 in	 anticancer	 and	 anti‐
microbial	 activity	 [32,33].	 A	molecular	modeling	 study	 using	
the	Molecular	Operating	Environment	(MOE)	[34]	module	was	
performed	 in	 order	 to	 rationalize	 the	 observed	 anticancer	
activity	 of	 APT,	 H2L	 and	 Ag(I),	 Mn(II)	 and	 Ni(II)	 complex.	
Molecular	 docking	 studies	 further	 helped	 in	 explaining	 the	
mode	of	action	of	the	compounds	through	their	various	inter‐
actions	 with	 the	 active	 sites	 of	 the	 dihydrofolate	 reductase	
(DHFR)	enzyme.	
Docking	and	molecular	modeling	calculations	were	carried	
out	 in	 the	Faculty	 of	 Pharmacy,	Alexandria	University,	Egypt.	




as	 the	computational	 software.	All	 of	 the	minimizations	were	
performed	with	MOE	until	 a	 RMSD	 gradient	 0.05	Kcal/mol⋅Å	
with	 MMFF94X	 force	 field	 and	 the	 partial	 charges	 were	
automatically	calculated.	
The	 coordinates	 of	 the	X‐ray	 crystal	 structure	 of	methot‐
rexate	 (MTX)	were	bound	 to	dihydrofolate	 reductase	 (DHFR)	
enzyme	(PDB	ID:	4DFR).	Enzyme	structures	were	checked	for	
missing	 atoms,	 bonds	 and	 contacts.	 Hydrogen	 atoms	 were	
added	 to	 the	 enzyme	 structure.	Water	 molecules	 and	 bound	
ligands	 were	 manually	 deleted.	 The	 ligand	 molecule	 was	
constructed	 using	 the	 builder	 molecule	 and	 was	 energy	
minimized.	 The	 active	 sites	 were	 generated	 using	 the	 MOE‐
Alpha	 site	 finder.	 Dummy	 atoms	 were	 created	 from	 the	
obtained	 alpha	 spheres.	 Compounds	were	 docked	within	 the	
dihydrofolate	reductase	active	sites	using	the	MOE‐Dock	with	
simulated	 annealing	 used	 as	 the	 search	 protocol	 and	 a	
MMFF94X	 molecular	 mechanics	 force	 field	 for	 8000	
interactions.	 The	 lowest	 energy	 conformation	 was	 selected	









bidentate	 sites,	 and	 was	 identified	 by	 elemental	 analysis,	
melting	 point,	 infrared,	 UV‐Visible,	 1H	 NMR	 and	mass	 spect‐
rum	 (Figure	 1)	 and	 fits	 with	 the	 data	 cited	 in	 the	 literature	
[20].	 The	 ligand	 reacted	with	 Ag(I),	 Mn(II),	 Co(II)	 and	 Ni(II)	


















































The	 geometrical	 structures	 of	 the	 complexes	 were	
identified	 and	 characterized	 using	 elemental	 analyses	 and	
infrared,	 UV‐visible,	 mass	 spectral	 data.	 Also,	 TGA,	 magnetic	
susceptibility	 and	 molar	 conductivity	 measurements	 were	





The	 characteristic	 vibrational	 frequencies	 and	 their	
tentative	 assignments	 for	 the	 H2L	 ligand	 and	 its	 transition	
metal	 complexes	 are	 listed	 in	Table	2.	The	assignments	were	
aided	 by	 comparison	with	 the	 vibrational	 frequencies	 of	 the	
free	ligand	and	its	related	compounds	[11,35,36]. 	
The	 shift	 of	 the	 stretching	 frequencies	 of	 the	 azomethine	
ν(C=N)	group	of	the	metal	complexes	to	lower	frequencies	that	
lie	 in	 the	 range	 of	 1620‐1580	 cm‐1,	 compared	 with	 the	 free	
ligand	 band	 at	 1629	 cm‐1,	may	be	 due	 to	 the	 coordination	 of	
the	 two	 azomethine	 groups	 to	metal	 ions	 [11,35].	 The	 broad	
bands	 in	 the	 range	 of	 3410‐3291	 cm‐1	 are	 assigned	 to	 the	
stretching	 frequencies	 of	 the	 ν(OH)	 of	 the	 water	 molecules	
associated	 to	 the	complexes	which	are	also	 confirmed	by	 the	
elemental	analyses	and	TGA	data.	The	weak	bands	in	the	two	
ranges	(579‐542	cm‐1)	and	(459‐439	cm‐1),	are	assigned	to	the	
stretching	 frequencies	 of	 the	 ν(M‐O)	 and	 ν(M‐N)	 bands,	
respectively,	supporting	 that	 the	bonding	of	 the	 ligand	 to	 the	
metal	 ions	 is	achieved	by	 the	phenolic	oxygen	atoms	and	 the	
azomethine	 and	 amine	 nitrogen	 atoms	 of	 the	 ligand.	 The	
unidentate	 nitrate	 group	 possesses	 three	 non‐degenerated	
modes	 of	 the	 vibrations	 (νs,	 νs’	 and	 νas),	 which	 appeared	 at	
1409,	1311	and	810	cm‐1.	The	νs(NO3‐)	of	the	unidentate	NO3‐	is	
markedly	shifted	to	lower	frequencies	compared	to	that	of	the	
free	 nitrate	 (1700‐1800	 cm‐1)	 [37].	 This	 could	 be	 a	 factor	
measuring	 the	 covalent	 bond	 strength	 formed	 due	 to	 the	
transfer	of	 an	electron	density	 from	NO3‐	 to	 the	metal	 ion.	 In	
complexes	 Mn(II),	 Co(II)	 and	 Ni(II),	 the	 NO3‐	 ions	 behave	 as	
free	 ionic	 groups	 and	 do	 not	 coordinate	with	 the	metal	 ions	
where	 their	vibrations	appeared	at	 (1751‐1742	cm‐1),	 (1383‐
1382	 cm‐1)	 and	 (856‐839	 cm‐1),	 respectively.	 The	 Ag(I)	
complex	did	not	show	such	vibrational	 transitions	 for	nitrate	






It	 is	 possible	 to	 draw	 up	 the	 electronic	 transitions	 and	
predict	 the	 geometry	 with	 the	 aid	 of	 magnetic	 moments	 of	
most	 metal	 ions.	 Table	 3	 lists	 the	 characteristic	 electronic	
absorption	bands,	magnetic	moments	and	molar	conductance	
of	 the	 H2L	 ligand	 and	 its	metal	 complexes	 in	 DMF	 solutions.	
The	electronic	transitions	due	to	the	organic	H2L	ligand	in	the	
metal	complexes,	showed	the	absorption	bands	of	the	π	→	π*	
and	n	→	π*	 transitions	 results	 from	 the	C=N	and	C=C	groups	
and	 appeared	 at	 324‐315	 and	 412‐408	 nm	 regions,	
respectively.	 These	 values	 are	 lower	 than	 the	 corresponding	
absorption	bands	 for	 the	H2L	 ligand,	which	were	observed	at	
324	 and	 417	 nm,	 respectively.	 This	 may	 be	 due	 to	 the	
coordination	of	the	nitrogen	and	oxygen	atoms	of	 the	 ligands	
to	 the	metal	 ions.	Also,	other	 two	bands	were	observed	 in	all	
electronic	spectra	of	the	complexes,	which	persist	at	the	same	
positions	 compared	 to	 the	 electronic	 spectra	 of	 the	 free	 H2L	
ligand,	which	are	the	two	bands	due	to	the	1La	→	1A	and	1Lb	→	
















the	 ligand	 transitions	 and	 is	 not	 possible	 to	 identify.	 The	
magnetic	 moment	 was	 measured	 and	 gives	 6.83	 B.M.	 This	




bands	were	observed	 in	 the	 visible	 region,	 the	 former	one	 is	
due	 to	 4T1g(F)	→	 4A2g(F)	 (ν2)	 transition,	which	 is	 observed	 at	
14600	 cm‐1.	 The	 second	 band	 due	 to	 4T1g(F)	 →	 4T1g(P)	 (ν3)	
transition	 is	observed	at	19470	 cm‐1.	The	 third	near	 infrared	
band	at	9430	cm‐1	was	assigned	to	4T1g	→	4T2g	transition	(ν1).	
The	Co(II)	complex	showed	the	magnetic	moment	at	4.90	B.M.	
at	 room	 temperature,	where	 the	 usual	 octahedral	 complexes	












	 	 	 	 	 (2)	
	
which	 gave	 4870	 cm‐1	 and	 506	 cm‐1,	 respectively.	 The	metal	
Co(II)	 d‐electrons	 will	 be	 partly	 shared	 by	 the	 ligand.	 The	
covalence	 character	 can	 be	 evaluated	 from	 the	 free	 ion	 of	
Co(II)	which	has	B	=	970	 cm‐1	 [40].	Thus,	 the	 expression	β	=	
B/B	 =	 0.522,	 indicates	 the	 covalent	 interaction	 between	 the	
ligand	to	Co(II)	in	the	complex.	
The	 electronic	 spectrum	 of	 the	 yellow	 Ni(II)	 complex	
showed	 two	 bands	 at	 10000	 and	 16000	 cm‐1	 which	 are	
assigned	to	3A2g	→	3T2g	(ν1)	and	3A2g	→	3T1g(F)	(ν2)	transitions	
in	 ther	 d8	 octahedral	 geometry.	 The	 measured	 value	 of	 the	
magnetic	 moment	 for	 Ni(II)	 complex	 was	 3.21	 B.M.,	 which	
confirms	 the	 octahedral	 structure	 [41,42].	 The	 third	 3A2g	 →	
3T1g(P)	ν3	transition	was	obscured	from	the	charge	transfer	of	




1o v  	 	 	 	 	 	 (3)	
	
2 1 2 1
2 1
( 2 )( )3 (5 9 )
v v v vB
v v
  
	 	 	 	 (4)	
		
3 2 115 3B v v v   	 	 	 	 	 (5)	
	
which	 gave	 10000,	 800	 and	 26000	 cm‐1,	 respectively.	 The	
metal	Ni(II)	d‐electrons	will	be	partly	shared	by	the	ligand;	i.e.,	
will	 spend	 <	 100%	 of	 their	 time	 on	 the	 metal.	 This	 can	 be	
evaluated	from	the	free	ion	of	Ni(II)	which	has	B	=	1080	cm‐1	
[40].	Thus,	the	expression	β	=	B/B	=	0.741.		
Thermal	 gravimetric	 analysis	 (TGA)	 of	 complex	 was	
performed	 to	 provide	 further	 proof	 in	 identifying	 the	
structure,	which	 shows	 three	 stages.	The	 first	 stage	 is	due	 to	
the	 loss	 of	 eight	 coordinated	 water	 molecules	 (weight	 loss;	
Calcd./Found%;	16.11/16.31%)	observed	 at	 100‐160	 °C.	 The	
second	stage	was	observed	at	480‐610	°C	and	is	due	to	the	loss	
of	 2NO2	 molecules	 (weight	 loss;	 Calcd./Found%;	 10.29/	
10.36%).	 The	 third	 stage	was	 observed	 at	 650‐800	 °C	 and	 is	
due	to	the	dissociation	of	the	organic	ligand	moiety	within	the	
complex	 (weight	 loss;	 Calcd./Found%;	 56.82/	 56.72%).	 The	
residue	 was	 2NiO	 (weight	 loss;	 Calcd./Found%;	 16.79/	
17.07%).	 Figure	 2	 depicts	 the	 TGA‐DrTGA	 curves	 of	 [Ni2(L)	
(H2O)8](NO3)2	complex.		
The	 values	 of	 the	 molar	 conductivity	 for	 all	 complexes	
were	measured	 at	 22	 Ohm‐1cm2mol‐1,	 for	 Ag(I)	 complex	 and	
145‐154	 Ohm‐1cm2mol‐1,	 for	 Mn(II),	 Co(II)	 and	 Ni(II)	 comp‐
lexes.	 These	 values	 are	 consistent	 with	 the	 electrolytic	 and	





draw	 up	 the	 tentative	 structures	 of	 the	 transition	 metal	
complexes	 of	 the	 Schiff	 base	H2L	 ligand.	 Figure	3	 depicts	 the	





The	 Schiff	 base	 ligand	 and	 its	 metal	 complexes	 were	
evaluated	for	antimicrobial	activity	against	three	strain	Gram‐
positive	 bacteria	 (Staphylococcus	 aureus	 (RCMB	 010027),	
Streptococcus	pneumonia	(RCMB	010010)	and	Bacillus	subtilis	
(RCMB	010067)),	three	Gram‐negative	bacteria	(Pseudomonas	
aeruginosa	 (RCMB	 010043),	 Klebsiella	 pneumoniae	 (RCMB	
0010093)	and	Escherichia	coli	(RCMB	010052))	and	the	fungi	
Aspergillus	 fumigatus	 (RCMB	 02568)	 and	 Candida	 albicans	
(RCMB	05036).	The	obtained	antimicrobials	are	presented	 in	
Table	 4.	 The	 Schiff	 base	 ligand	 was	 found	 to	 be	 biologically	
active	 against	 the	microorganisms.	 Table	 4	 also	 shows	 all	 of	
the	 metal	 complexes	 exhibit	 antimicrobial	 activity	 in	 one	 or	































H2L	 29.1±0.37	 26.2±0.36	 28.1±0.63 28.6±0.63 18.4±0.58 29.1±0.37 26.3±0.44	 25.4±0.58
[Ag2(L)(H2O)4]	 15.2±0.38	 14.6±0.58	 16.2±0.58 20.6±0.22 25.4±0.29 13.7±0.25 12.6±0.58	 13.6±0.58
[Mn2(L)(H2O)8](NO3)2	 13.5±0.41	 18.0±0.19	 15.0±0.63 17.9±0.52 19.3±0.36 12.6±0.34 17.4±0.46	 16.0±0.25
[Co2(L)(H2O)8](NO3)2	 17.9	±0.72	 16.9±0.44	 19.3±0.25 14.4±0.35 18.2±0.19 14.9±0.44 15.6±0.44	 16.2±0.58
[Ni2(L)(H2O)8](NO3)2	 20.3±0.38	 17.6±0.58	 17.7±0.43 14.9±0.44 18.2±0.25 20.3±0.38 17.6±0.58	 18.2±0.25









50	 25	 12.5	 6.25	 3.125	 1.56	 0	 IC50		
H2L	 5.94±0.156	 9.21±0.678	 13.76±0.354 26.04±0.567 51.39±0.890 68.74±0.821	 100 3.30
[Ag2(L)(H2O)4]	 5.06±0.298	 8.85±0.943	 12.92±0.456	 31.43±0.789	 43.32±0.267	 57.20±0.932	 100	 2.37	
[Mn2(L)(H2O)8](NO3)2	 16.18±0.497	 29.72±0.934	 41.63±0.321	 79.85±0.213	 88.64±0.992	 94.55±0.289	 100	 11.10	
[Co2(L)(H2O)8](NO3)2	 6.98±0.349	 12.86±0.930	 19.78±0.876	 34.64±0.768	 49.78±0.987	 61.36±0.765	 100	 3.09	
[Ni2(L)(H2O)8](NO3)2	 7.54±0.543	 13.93±0.589	 22.65±0.234 36.74±0.654 54.26±0.432 78.31±0.891	 100 3.88








Although	 Ag(I)	 complex	 showed	 very	 high	 activity	 as	
antimicrobial	 activity,	 the	Mn(II)	complex	showed	a	dramatic	
low	 activity	 for	 all	 Gram‐positive	 bacteria,	 and	 less	 than	 the	
control	 in	 Gram‐negative	 bacteria	while	 showing	 remarkable	
effect	on	the	fungi.		
It	is	known	that	chelation	tends	to	make	the	ligand	act	as	a	
more	 powerful	 and	 potent	 bacterial	 agent.	 One	 possible	
explanation	for	this	increase	in	activity	upon	chelation	is	that,	
in	 chelated	 complexes,	 the	 positive	 charge	 of	 the	 metal	 is	
partially	 shared	with	 donor	 atoms	 present	 on	 the	 ligands	 so	
there	 is	 an	 electron	 delocalization	 over	 the	 whole	 chelated	
ring.	 This,	 in	 turn,	 increases	 the	 lipoid	 layers	 of	 the	bacterial	
membranes.	Generally,	 it	 is	suggested	the	chelated	complexes	
deactivate	various	cellular	enzymes,	which	play	a	vital	role	 in	
various	 metabolic	 pathways	 of	 these	 microorganisms.	 Other	
factors	 which	 may	 also	 explain	 the	 increasing	 biological	
activity	of	the	metal	complexes	as	compared	to	the	ligand	from	






as	 well	 as	 its	 four	 metal	 complexes	 was	 investigated	 on	 the	
human	 colon	 carcinoma	 (HCT‐116)	 cell	 line.	 Ag(I)	 and	Co(II)	
complexes	 with	 selectivity	 index	 (S.I.)	 =	 17.00	 and	 15.63;	
respectively,	 exhibited	 better	 activity	 than	 the	 methotrexate	





were	 significantly	 different	 from	 those	 on	 the	 human	 colon	
carcinoma	 (HCT‐116)	 cell	 line	 (Table	 5).	 These	 findings	
revealed	that	Ag(I)	and	Co(II)	required	high	concentrations	to	
be	 cytotoxic	 on	 normal	 cells	 while	 only	 low	 concentrations	
were	 enough	 to	 produce	 the	 same	 effect	 on	 the	 colon	








50	 25	 12.5 6.25 3.125 1.56	 0	 CC50
H2L	 19.87±0.543	 48.62±0.980	 74.83±0.256	 83.22±0.634	 91.74±0.239	 97.31±0.393	 100	 24.30		
[Ag2(L)(H2O)4]	 41.74±0.908	 62.96±0.102	 74.54±0.367	 88.12±0.746	 93.76±0.333	 98.24±0.352	 100	 40.30		
[Mn2(L)(H2O)8](NO3)2	 80.61±0.237	 89.53±0.167 94.36±0.578 98.62±0.120 100.0±0.246 100.0±0.942	 100 95.	40	
[Co2(L)(H2O)8](NO3)2	 49.30±0.772	 59.72±0.699 75.38±0.756 87.53±0.745 94.81±0.238 98.76±0.114	 100 48.30	
[Ni2(L)(H2O)8](NO3)2	 40.91±0.445	 57.23±0.576 69.47±0.834 81.54±0.634 90.08±0.123 94.71±0.350	 100 36.10	





Compound	 CC50	(g/mL)	 CC50 (M) IC50 (g/mL) IC50 (M)	 S.I.	
H2L	 24.30	 47.65 3.30 6.47 7.36	
[Ag2(L)(H2O)4]	 40.30	 50.63 2.37 2.97 17.00
[Mn2(L)(H2O)8](NO3)2	 95.40	 107.67 11.10 12.53 8.59	
[Co2(L)(H2O)8](NO3)2	 48.30	 54.03 3.09 3.46 15.63
[Ni2(L)(H2O)8](NO3)2	 36.10	 40.38	 3.88	 4.34	 9.30	
MTX	 42.70	 94.05 3.21 7.07 13.30
a	 The	 inhibitory	 activity	 against	 colon	 carcinoma	 (HCT‐116)	 cell	 line	 was	 detected	 under	 for	 (50,	 25,	 12.5,	 6.25,	 3.125,	 1.56	 and	 0.00	 g)	 samples	












the	 selectivity	 index	 (SI),	 which	 is	 the	 ratio	 of	 the	 concent‐
ration	that	causes	50%	death	to	African	green	monkey	kidney	






The	 recent	 determination	 of	 the	 three	 dimensional	 co‐
crystal	structure	of	dihydrofolate	reductase	combined	with	the	
potent	 inhibitor,	 methotrexate	 (MTX)	 (PDB	 ID:	 4DFR)	
(Structure	 1),	 has	 led	 to	 the	 development	 of	 a	model	 for	 the	
topography	of	the	binding	site	of	dihydrofolate	reductase.	MOE	
(Molecular	 Operating	 Environment)	 docking	 studies	 of	 the	
inhibitors	were	 performed	using	 the	 dihydrofolate	 reductase	
(DHFR)	 co‐crystallized	 with	 methotrexate	 (MTX)	 (PDB	 ID:	
4DFR)	as	a	template.	Scheme	1	thus	illustrates	the	represent‐
tative	keys	for	the	type	of	interaction	between	substrates	and	
the	 DHFR,	 which	 can	 be	 used	 as	 a	 guide	 in	 the	 docking	 in	
Figures	4‐7.	
Docking	 of	 MTX	 into	 the	 DHFR	 active	 site	 revealed	 that	
hydrogen	 bond	 interactions	 beside	 hydrophobic	 interactions	
were	considered	responsible	for	the	observed	affinity	as	it	acts	
as	 a	 hydrogen	 bond	 donor	 to	 the	 backbone	 Ile	 5	 and	 Ile	 94	
residues	 and	 the	 side	 chain	 Asp	 27	 residue.	 It	 also	 acts	 as	 a	
hydrogen	bond	accepter	 to	Arg	52	and	Arg	57	 residues.	This	



















Docking	 of	H2L	 ligand	 into	 the	DHFR	 active	 site	 revealed	





Docking	 of	 Ag(I)	 complex	 into	 the	 DHFR	 active	 site	
revealed	 the	presence	of	hydrogen	bond	 interaction	between	
the	 hydroxyl	 groups	 as	 they	 act	 as	 a	 hydrogen	 bond	 donor	
either	with	side	chain	Asp	21	residue	(2.56,	3.05	and	1.89	Å	)	
with	a	strength	of	13.7,	1.4	and	3%,	respectively;	or	with	the	
side	 chain	 Ser	 59	 residue	 (3.67	 Å)	 with	 a	 strength	 of	 2%.	
However,	it	showed	the	presence	of	a	hydrogen	bond	interact‐
tion	between	the	oxygen	atom	of	the	hydroxyl	group	as	it	acts	
as	 hydrogen	 bond	 acceptor	 either	 with	 side	 chain	 Leu	 22	
residue	 (2.76	 Å)	 with	 a	 strength	 of	 75.8%	 or	 with	 the	 side	
chain	Asn	64	residue	(2.79	and	2.72	Å	)	with	a	strength	of	1.6	
and	52.4%,	respectively.	Furthermore,	it	revealed	the	presence	




Docking	 of	 Mn(II)	 complex	 into	 the	 DHFR	 active	 site	
revealed	 the	presence	of	hydrogen	bond	 interaction	between	
two	oxygen	atoms	of	the	four	hydroxyl	groups,	as	they	act	as	a	
hydrogen	 bond	 acceptor	 either	 with	 the	 side	 chain	 Thr	 56	
residue	(3.47,	2.69	and	3.40	Å)	with	a	strength	of	2.6,	67.6	and	
3.7%,	 respectively;	 or	 with	 the	 side	 chain	 Thr	 121	 residue	
(2.36	 and	 2.68	Å)	with	 a	 strength	 of	 99	 and	 87.4%,	 respect‐
tively.	Furthermore,	it	showed	the	presence	of	hydrogen	bond	
interaction	between	the	four	hydroxyl	groups,	as	they	act	as	a	
hydrogen	 bond	 donor	 either	 with	 the	 side	 chain	 Thr	 56	
residue	 (2.69	 and	 3.40	 Å)	with	 a	 strength	 of	 67.6	 and	 3.7%;	













In	 addition,	 it	 revealed	 the	 presence	 of	 hydrophobic	




Docking	 of	 Ni(II)	 complex	 into	 the	 DHFR	 active	 site	
revealed	 the	presence	of	hydrogen	bond	 interaction	between	
the	 hydroxyl	 groups	 as	 they	 act	 as	 a	 hydrogen	 bond	 donor	
either	with	side	chain	Thr	56	residue	(2.55	and	1.96	Å)	with	a	
strength	of	7.8	and	57.2%,	respectively;	Ser	59	residue	(3.51,	
2.73	 and	 2.47	 Å)	 with	 a	 strength	 of	 1.2,	 90.8	 and	 99.5%,	
respectively;	 or	 Asn	 64	 residue	 (3.80	 Å)	 with	 a	 strength	 of	




99.5	 %;	 respectively	 or	 with	 the	 side	 chain	 Arg	 70	 residue	
(3.23,	 3.30	 and	 3.30	 Å)	with	 a	 strength	 of	 10,	 9.6	 and	 6.3%,	
respectively.	 Furthermore,	 it	 revealed	 the	 presence	 of	
hydrophobic	 interactions	 between	 other	 atoms	 in	 the	
compound	and	many	amino	acid	residues:	IIe	16,	Phe	31,	Arg	





The	 thiazole	 Schiff	 base	 ligand	was	allowed	 to	 react	with	
silver(I),	manganese(II),	 cobalt(II)	 and	 nickel(II)	 ions,	 with	 a	
1:2	 molar	 ratio	 (ligand:metal	 ion).	 All	 reactions	 afforded	
binuclear	 complexes	 for	 H2L	 with	 either	 octahedral	 or	
tetrahedral	geometries.	The	bonding	sites	are	the	azomethine	
nitrogen	atoms	and	the	phenolic	oxygen	atoms.	The	ligand	and	
its	 silver(I)	 complex	 enhanced	 significant	 antimicrobial	 acti‐
vity	 compared	 with	 standard	 antifungal	 and	 antibacterial	
agents.	 In	 the	 cytotoxicity	 study,	 Ag(I)	 and	 Co(II)	 complexes	
showed	 the	 highest	 inhibitory	 effects	 at	 concentrations	 that	




predict	 their	 mode	 of	 action	 as	 anticancer	 drugs.	 The	
compounds	 show	 strong	 interactions	 with	 the	 dihydrofolate	
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